Related Experiment Video
Updated: Sep 10, 2025
Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
Published on: November 9, 2020
Disrupted Myelination in FAHN: Insights from a Patient-Specific hiPSC Neuron-Oligodendrocyte Model
Fatima Efendic1, Andreas Hermann1,2,3, Moritz J Frech1,2
1Translational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, 18147 Rostock, Germany.
Abstract:
Fatty-acid-hydroxylase-associated neurodegeneration (FAHN) is a rare neurodegenerative disorder caused by loss-of-function mutations in the FA2H gene, leading to impaired enzymatic activity and resulting in myelin sheath instability, demyelination, and axonal degeneration. In this study, we established a human in vitro model using neurons and oligodendrocytes derived from induced pluripotent stem cells (hiPSCs) of a FAHN patient. This coculture system enabled the investigation of myelination processes and myelin integrity in a disease-relevant context. Analyses using immunofluorescence and Western blot revealed impaired expression and localisation of key myelin proteins in oligodendrocytes and cocultures. FA2H-deficient cells showed reduced myelination, shortened internodes, and disrupted formation of the nodes of Ranvier. Additionally, we identified autophagy defects-a hallmark of many neurodegenerative diseases-including reduced p62 expression, elevated LC3B levels, and impaired fusion of autophagosomes with lysosomes. This study presents a robust hiPSC-based model to study FAHN, offering new insights into the molecular pathology of the disease. Our findings suggest that FA2H mutations compromise both the structural integrity of myelin and the efficiency of the autophagic machinery, highlighting potential targets for future therapeutic interventions.
Insights
Fatty-acid-hydroxylase-associated neurodegeneration (FAHN) is a rare genetic disorder. This study uses patient-derived stem cells to model FAHN, revealing myelin defects and autophagy dysfunction, suggesting new therapeutic targets.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Fatty-acid-hydroxylase-associated neurodegeneration (FAHN) is a rare neurodegenerative disorder.
- It results from loss-of-function mutations in the *FA2H* gene, impacting myelin sheath stability.
- This leads to demyelination and axonal degeneration.
Purpose of the Study:
- To establish a human in vitro model for FAHN using patient-derived induced pluripotent stem cells (hiPSCs).
- To investigate myelination processes and myelin integrity in a disease-relevant context.
- To explore the molecular pathology and identify potential therapeutic targets for FAHN.
Main Methods:
- Generation of neurons and oligodendrocytes from FAHN patient hiPSCs.
- Establishment of a hiPSC-derived coculture system for studying myelination.
- Analysis using immunofluorescence, Western blot, and assessment of autophagy markers (p62, LC3B).
Main Results:
- Impaired expression and localization of key myelin proteins were observed.
- *FA2H*-deficient cells exhibited reduced myelination, shortened internodes, and disrupted nodes of Ranvier.
- Autophagy defects were identified, including impaired autophagosome-lysosome fusion.
Conclusions:
- A robust hiPSC-based model for FAHN was successfully developed.
- *FA2H* mutations compromise both myelin structural integrity and autophagic machinery efficiency.
- These findings highlight potential therapeutic targets for FAHN interventions.
